Drug Type Small molecule drug |
Synonyms Avagacestat (USAN), BMS-708163, BMS-708163-01 |
Target |
Action inhibitors |
Mechanism γ-secretase inhibitors(Gamma-secretase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H17ClF4N4O4S |
InChIKeyXEAOPVUAMONVLA-QGZVFWFLSA-N |
CAS Registry1146699-66-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 2 | United States | 01 Feb 2009 | |
| Alzheimer Disease | Phase 2 | Denmark | 01 Feb 2009 | |
| Alzheimer Disease | Phase 2 | Finland | 01 Feb 2009 | |
| Alzheimer Disease | Phase 2 | Sweden | 01 Feb 2009 |
Phase 2 | 263 | kpbivwqsqs(ceyaqmrxkw) = jhbzszpuvs okymxtdwqx (zosfcbcvyu ) | Negative | 01 Nov 2015 | |||
Placebo | kpbivwqsqs(ceyaqmrxkw) = amyphcdamb okymxtdwqx (zosfcbcvyu ) | ||||||
Phase 2 | 209 | hempkfxdzk(tfaibytylw) = paciwtzlfi tgjhkbzjhf (jbderperbh ) | - | 01 Nov 2012 | |||
hempkfxdzk(tfaibytylw) = jnyheqkxrs tgjhkbzjhf (jbderperbh ) | |||||||
Not Applicable | - | - | wzvkpadfvz(mnbjvnwokm) = weoauzodhi pgylllmytw (khynbfmceo ) | - | 01 Jul 2010 | ||
qwuxvovjyg(efdnfyxiht) = mamzilwhvd vysejmivyu (ixgptlftrf ) View more |





